Xbrane Biopharma is a Swedish biopharmaceutical company that develops biosimilar medicines, which are copies of biologic drugs that have lost patent protection. Its work centres on treatments for eye disorders and on protein production technology, including a bacterial expression platform used to manufacture proteins. The company serves pharmaceutical markets through partnerships and licensing arrangements, and it is based in Sweden, where its development and production activities are organised.
The shares are listed on the Nasdaq Stockholm in Sweden under the code XBRANE, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #234 of 912 on the Nasdaq Stockholm · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendStrong
94/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average76.1%
From 52-week high0.0%
MomentumStrong
86/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return64.9%
6-month return74.3%
12-month, skipping last month1.1%
Stability (higher is calmer)Weak
26/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)88.7%
Worst drawdown, 1 year (smaller is calmer)-53.4%
LiquidityFair
58/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.89M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
52-wk range 5.42 – 20.00Daily closes, split-adjusted
Signals
50-day average11.08
200-day average9.88
Golden/death cross (60d)None
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)1.55
Technical summary
Daily
Strongly bullish
12 bullish · 2 neutral · 2 bearish
Weekly
Bullish
8 bullish · 0 neutral · 4 bearish
Monthly
Bullish
5 bullish · 0 neutral · 3 bearish
Moving averages (daily)
SMA 10
12.75
Bullish
EMA 10
13.30
Bullish
SMA 20
12.59
Bullish
EMA 20
12.61
Bullish
SMA 50
11.08
Bullish
EMA 50
11.59
Bullish
SMA 100
10.72
Bullish
EMA 100
11.04
Bullish
SMA 200
9.88
Bullish
EMA 200
12.47
Bullish
Oscillators (daily)
RSI (14)
72.59
Bearish
MACD (12, 26)
0.81
Bullish
Momentum (12)
24.73
Bullish
Stochastic %K (14)
71.11
Neutral
Williams %R (14)
-28.89
Neutral
CCI (20)
259.7
Bearish
Pivot points (classic, last session)
S3
4.43
S2
8.07
S1
12.73
Pivot
16.37
R1
21.03
R2
24.67
R3
29.33
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
